Bioprocessing offers key market opportunities in optimizing upstream and downstream processes to enhance yield and purity of pharmaceuticals, biofuels, and specialty chemicals. Innovations in cell ...

Over two-thirds of biopharmaceutical manufacturers now report that their facility is experiencing capacity bottlenecks due to downstream processing. A number of factors continue to converge to create ...

Many recombinant viral vectors for expression of ectopic antigens mimic a natural infection and can induce a robust immune response against certain pathogens and tumors. Host-restricted poxviruses and ...

Crude oil price fluctuations affect upstream and downstream companies differently. Upstream firms benefit from higher prices, ...

Biopharmaceutical downstream processing requires precise control of multiple unit operations—from chromatography and filtration to viral inactivation—to ensure product quality and therapeutic efficacy ...

Discover the crucial exploration and production stages in upstream oil and gas. Understand how drilling and extraction are ...

Upstream titers of 3–5 g/L, and up to 10–13 g/L, are outpacing downstream capacity, creating chromatography, filtration, and UF/DF throughput bottlenecks that elevate cost and delay timelines. Complex ...

Osmolality is a well-established parameter for upstream bioprocessing, formulation, analytical development and QC applications throughout the manufacturing of biological drugs. A recent publication ...

With the recent FDA approval of the CAR T-cell therapies Kymriah ® from Novartis and Yescarta ® from Kite Pharma, there has been a renewed interest in bioprocessing and the manufacturing facilities ...

Indonesia’s refinery push risks deeper crude imports unless upstream oil exploration accelerates to support energy security.

Critical minerals supply chain risk isn't primarily a sourcing problem, supply chain expert Kenneth Johnson argues — it's a ...